Skyfield Capital
Overview
Skyfield Capital (Hangzhou Honghou Asset Management) is a China-based investment firm that manages growth and expansion funds with a focus on the pharmaceutical and biotechnology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hangzhou Eli Radiopharma Co., Ltd. | Nov 2026 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Skyfield Capital based?
Skyfield Capital is headquartered in Hangzhou, China.
When was Skyfield Capital founded?
Skyfield Capital was founded in 2015.
How many portfolio companies does Skyfield Capital have?
Skyfield Capital has 1 portfolio company in Caplight's dataset.
What are some companies in Skyfield Capital's portfolio?
Portfolio companies visible on Caplight include Hangzhou Eli Radiopharma Co., Ltd..
What was Skyfield Capital's most recent investment shown here?
Skyfield Capital's most recent investment in this portfolio sample was in Hangzhou Eli Radiopharma Co., Ltd. in 2026.
What sectors does Skyfield Capital focus on?
Skyfield Capital focuses on Healthcare & Life Sciences.
What company stages does Skyfield Capital focus on?
Stage focus information for Skyfield Capital is not publicly available.
What is Skyfield Capital's AUM?
Skyfield Capital's assets under management are estimated at over $2.7B.